{
  "meta": {
    "title": "27_Acute_Myeloid_Leukemia_Aml",
    "url": "https://brainandscalpel.vercel.app/27-acute-myeloid-leukemia-aml-a47eebdf.html",
    "scrapedAt": "2025-11-30T12:33:34.046Z"
  },
  "questions": [
    {
      "text": "Which of the following is not a myeloid marker?",
      "choices": [
        {
          "id": 1,
          "text": "CD64"
        },
        {
          "id": 2,
          "text": "CD3"
        },
        {
          "id": 3,
          "text": "CD11b"
        },
        {
          "id": 4,
          "text": "CD117"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>CD3</strong> is not a myeloid marker. It is a <strong>T-cell lymphoid marker</strong>.</p>\n<p>Cell markers:</p>\n<ul>\n<li><strong>B-cell</strong>:&nbsp;CD10, CD19, CD20, CD22, CD23, CD24, CD79b, CD103, Pax-5, kappa, lambda, CD200, cytoplasmic kappa, cytoplasmic lambda</li>\n<li><strong>T- cell</strong>:&nbsp;CD1, CD2, CD3, CD4, CD5, CD6,CD7, CD8, TCR apha-beta, TCR gamma-delta, cytoplasmic CD3</li>\n<li><strong>Myeloid</strong>:&nbsp;CD11b, CD13, CD14, CD15, CD33, CD64, CD 117, myeloperoxidase</li>\n</ul><hr><h3>Related Pearl: Immune Cell Antigens Detected by Monoclonal Antibodies</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Immune cells</strong></p>\n</td>\n<td>\n<p><strong>Antigens associated</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>T-cell</p>\n</td>\n<td>\n<p>CD1, CD3, CD4, CD5, CD8</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>B-cell</p>\n</td>\n<td>\n<p>CD10, CD19, CD20, CD21, CD23, CD79a</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Monocyte or macrophage</p>\n</td>\n<td>\n<p>CD11c, CD13, CD14, CD15, CD33, CD64</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>NK-cell</p>\n</td>\n<td>\n<p>CD16, CD56</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hematopoietic stem cells</p>\n</td>\n<td>\n<p>CD34</p>\n</td>\n</tr>\n<tr>\n<td>Leukocyte common antigen</td>\n<td>CD45</td>\n</tr>\n<tr>\n<td>Activated B cells, T cells, monocytes, and Reed-Sternberg cells</td>\n<td>CD30</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB3640",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following is the most common type of acute myeloid leukemia?",
      "choices": [
        {
          "id": 1,
          "text": "AML M1"
        },
        {
          "id": 2,
          "text": "AML M2"
        },
        {
          "id": 3,
          "text": "AML M3"
        },
        {
          "id": 4,
          "text": "AML M7"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The <strong>most</strong> common type of acute myeloid leukemia (AML) is <strong>AML - M2</strong> or <strong>AML</strong> <strong>with maturation</strong>.</p>\n<p>The <strong>least</strong> common type of AML is <strong>AML M7 </strong>or megakaryocytic.</p><hr><h3>Related Pearl: FAB classification</h3><table>\n<tbody>\n<tr>\n<td><strong>FAB classification</strong></td>\n<td><strong>High-Yield points</strong></td>\n</tr>\n<tr>\n<td>M0-minimal differentiation</td>\n<td>-</td>\n</tr>\n<tr>\n<td>M1-without maturation</td>\n<td>-</td>\n</tr>\n<tr>\n<td>M2 - with maturation</td>\n<td>\n<ul>\n<li>Most common</li>\n<li>t(8,21)</li>\n<li>Chloromas</li>\n<li>Good prognosis</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>M3 - promyelocytic</td>\n<td>\n<ul>\n<li>Young-good prognosis</li>\n<li>t(15,17)-intermediate</li>\n<li>Auer rods</li>\n<li>DIC</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>M4 - myelomonocytic</td>\n<td>\n<ul>\n<li>inv 16</li>\n<li>t(16,16)</li>\n<li>Eosinophilia</li>\n<li>Gingival hyperplasia</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p>M5a - monoblastic</p>\n<p>M5b - monocytic</p>\n</td>\n<td>\n<ul>\n<li>Organ infiltration</li>\n<li>Gingival hyperplasia</li>\n<li>Increased WBC count, fever</li>\n<li>Sweet syndrome</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>M6 - erythroid</td>\n<td>\n<ul>\n<li>Therapy related</li>\n<li>Erythemic myelosis, Di&nbsp;Guglielmo disease</li>\n<li>Poor prognosis</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>M7 - megakaryocytic</td>\n<td>\n<ul>\n<li>CD 41/61</li>\n<li>Bad prognosis</li>\n<li>Down syndrome (good prognosis)</li>\n<li>Bone marrow fibrosis (increased PDGF)</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB3646",
      "difficulty": "medium"
    },
    {
      "text": "What is the most common subtype of acute myeloid leukemia seen in patients with Down's syndrome?",
      "choices": [
        {
          "id": 1,
          "text": "AML M3"
        },
        {
          "id": 2,
          "text": "AML M4"
        },
        {
          "id": 3,
          "text": "AML M6"
        },
        {
          "id": 4,
          "text": "AML M7"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The most common subtype of AML seen in <strong>Down's syndrome</strong> is acute myeloid leukemia-M7 <strong>(AML - M7)&nbsp;</strong>or <strong>acute megakaryocytic leukemia.</strong></p>\n<p>Myeloid proliferations of Down's syndrome are usually megakaryoblastic. It includes:</p>\n<ul>\n<li>Transient abnormal myelopoiesis (TAM) - occurs&nbsp;at birth or within days of birth and resolves in 1 to 2 months</li>\n<li>Myeloid leukemia associated with Down syndrome -&nbsp;occurs later, but usually in the first 3 years of life.</li>\n</ul>\n<p>Both are characterized by<strong> GATA1 </strong>mutations and mutations of the <strong>JAK-STAT</strong> pathway.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB3662",
      "difficulty": "easy"
    },
    {
      "text": "A 35-year-man presents with nosebleeds, bleeding gums, and multiple ecchymoses. Lab investigations show the following findings. The blasts are positive for CD33. What is the most likely diagnosis?<div class='question-desc-html'><p>Hb: 8.5 g/dL</p>\n<p>Platelet count: 12,000/Cumm</p>\n<p>TLC: 52,000/Cumm with 83% blasts</p></div>",
      "choices": [
        {
          "id": 1,
          "text": "Acute myeloid leukemia"
        },
        {
          "id": 2,
          "text": "Acute lymphoblastic leukemia"
        },
        {
          "id": 3,
          "text": "Small Lymphocytic lymphoma"
        },
        {
          "id": 4,
          "text": "Myelodysplastic syndrome"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The given clinical scenario is suggestive of <strong>acute myeloid leukemia (AML)</strong>.</p>\n<p><strong>AML</strong>&nbsp;is a tumor of hematopoietic progenitors caused by acquired oncogenic mutations that impede differentiation, leading to the accumulation of immature myeloid blasts in the marrow.&nbsp;It occurs at all ages, but the incidence rises throughout life, peaking after 60 years of age.&nbsp;</p>\n<p>The peripheral smear shows blasts with <strong>abundant cytoplasm</strong>, fine <strong>azurophilic granules</strong>,&nbsp;Auer rods, and delicate nuclear chromatin with 1-4 prominent nucleoli. The blasts are <strong>positive</strong> for <strong>CD33.&nbsp;</strong>Occasionally, blasts are entirely absent from the blood (<strong>aleukemic leukemia</strong>).&nbsp;Bone marrow examination is essential to exclude acute leukemia in pancytopenic patients.</p>\n<p>&nbsp;</p><hr><h3>Related Pearl: WHO classification of Acute Myeloid Leukemia (AML)</h3><p>The 5th edition of WHO (2022) classification classifies&nbsp;acute myeloid&nbsp;leukemia (AML) as follows:</p>\n<p><strong>AML with defining genetic abnormalities&nbsp;(gene or chromosome changes):</strong></p>\n<ul>\n<li aria-level=\"1\">Acute promyelocytic leukemia with PML::RARA fusion</li>\n<li aria-level=\"1\">AML with RUNX1::RUNX1T1 fusion</li>\n<li aria-level=\"1\">AML with CBFB::MYH11 fusion</li>\n<li aria-level=\"1\">AML with DEK::NUP214 fusion</li>\n<li aria-level=\"1\">AML with RBM15::MRTFA fusion</li>\n<li aria-level=\"1\">AML with BCR::ABL1 fusion</li>\n<li aria-level=\"1\">AML with KMT2A rearrangement<sup>*</sup></li>\n<li aria-level=\"1\">AML with MECOM rearrangement</li>\n<li aria-level=\"1\">AML with NUP98 rearrangement</li>\n<li aria-level=\"1\">AML with NPM1 mutation</li>\n<li aria-level=\"1\">AML with CEBPA mutation</li>\n<li aria-level=\"1\">AML, myelodysplasia-related<sup>#</sup></li>\n<li aria-level=\"1\">AML with other defined genetic alterations</li>\n</ul>\n<p>&nbsp;<strong>AML, defined by differentiation:</strong></p>\n<ul>\n<li>AML with minimal differentiation</li>\n<li>AML without maturation</li>\n<li>AML with maturation</li>\n<li>Acute basophilic leukaemia</li>\n<li>Acute myelomonocytic leukaemia</li>\n<li>Acute monocytic leukaemia</li>\n<li>Acute erythroid leukaemia</li>\n<li>Acute megakaryoblastic leukemia</li>\n</ul>\n<p>Most AML with defining&nbsp;genetic abnormalities are diagnosed with &lt; 20% blasts except AML with BCR: ABL1 and AML with CEBPA mutation that require at least 20% blasts for diagnosis.</p>\n<p><span>*AML with KMT2A rearrangement is the new term that replaces &ldquo;AML with t(9;11)(p22;q23); KMT2A-MLLT3</span></p>\n<p><span>#AML with myelodysplasia-related changes has been renamed as AML, myelodysplasia-related (AML-MR).</span></p>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/95a0851a289e4ce89757c13901082f52.PNG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB3643",
      "difficulty": "easy"
    },
    {
      "text": "Peripheral smear of a patient with acute promyelocytic leukemia shows myeloblasts with the following finding. What are these made of?",
      "choices": [
        {
          "id": 1,
          "text": "Lysosomes"
        },
        {
          "id": 2,
          "text": "Golgi apparatus"
        },
        {
          "id": 3,
          "text": "Endoplasmic reticulum"
        },
        {
          "id": 4,
          "text": "Ribosomes"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The image shows <strong>Auer rods</strong> in myeloblasts.&nbsp;These are needle-shaped azurophilic intracytoplasmic inclusion bodies formed by the fusion of<strong> lysosomes</strong>.</p>\n<p>Auer rods contain peroxidase and lysosomal enzymes.&nbsp;Myeloblasts with bundles of Auer rods are called<strong>&nbsp;faggot cells</strong> and are seen in <strong>acute promyelocytic leukemia</strong>.</p>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/c33558f7f3f04be780d1f10abe5cc295.PNG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB3644",
      "difficulty": "hard"
    },
    {
      "text": "In which of the following conditions are Auer rods seen?<div class='question-desc-html'><ol>\n<li>Acute promyelocytic leukemia</li>\n<li>Acute monocytic leukemia</li>\n<li>Myelodysplasia</li>\n<li>Chronic myelomonocytic leukemia</li>\n<li>Acute lymphoblastic leukemia</li>\n</ol></div>",
      "choices": [
        {
          "id": 1,
          "text": "1 and 2 only"
        },
        {
          "id": 2,
          "text": "3, 4, and 5"
        },
        {
          "id": 3,
          "text": "1, 2, 3, 4, and 5"
        },
        {
          "id": 4,
          "text": "1, 3, and 4"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Auer rods</strong> are seen in:</p>\n<ul>\n<li>Acute promyelocytic leukemia</li>\n<li>Myelodysplastic syndromes</li>\n<li>Chronic myelomonocytic leukemia</li>\n</ul>\n<p>These are not seen in acute monocytic leukemia and acute lymphoblastic leukemia.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB3645",
      "difficulty": "medium"
    },
    {
      "text": "A 20-year-old male patient is diagnosed with acute myeloid leukemia. The peripheral blood smear picture is given in the image. The cell indicated by the arrow is best described as:",
      "choices": [
        {
          "id": 1,
          "text": "Auer rod"
        },
        {
          "id": 2,
          "text": "Flaming promyelocyte"
        },
        {
          "id": 3,
          "text": "Faggot cell"
        },
        {
          "id": 4,
          "text": "Dusky promyelocyte"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The given cell shows <strong>multiple Auer rods</strong> <strong>clustered together</strong> within a single cell resembling a bundle of sticks. Such cells have been termed as<strong> faggot cells</strong>&nbsp;(faggot in French means <strong>bundle of sticks</strong>). &nbsp;</p>\n<p>Since the question specifically asks about the <strong>cell</strong>, the best answer is faggot cell (not Auer rods).</p>\n<p>Option A: <strong>Auer rods</strong> are distinctive needle-like azurophilic granules present in many cases but particularly numerous in AML with the t(15;17) aberration (<strong>acute promyelocytic leukemia</strong>). &nbsp;</p>\n<p>Option B: The term <strong>flaming promyelocyte</strong>&nbsp;refers to cells that appear to be breaking apart, taking on a vibrant reddish-purple hue with the apparent liberation of granules into the surrounding cellular matrix.&nbsp;</p>\n<p>Option C: Promyelocytes containing fine granules appear dusky or hazy and are referred to as <strong>dusky promyelocytes</strong>.</p>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/3371682063654a5bbb0fb94cfb0fafb1.PNG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC6256",
      "difficulty": "medium"
    },
    {
      "text": "Increased levels of serum muramidase are seen in patients with which of the following conditions?",
      "choices": [
        {
          "id": 1,
          "text": "Acute myeloid leukemia - M4"
        },
        {
          "id": 2,
          "text": "Acute myeloid leukemia - M2"
        },
        {
          "id": 3,
          "text": "Acute myeloid leukemia - M6"
        },
        {
          "id": 4,
          "text": "Acute myeloid leukemia - M3"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Serum muramidase </strong>or<strong> lysozyme levels</strong> are seen to be increased in patients with<strong> acute myelomonocytic</strong>&nbsp;<strong>leukemia</strong> (AML - M4).</p>\n<p>It is also increased in chronic myelomonocytic leukemia and chronic myeloid leukemia (CML).</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB3654",
      "difficulty": "hard"
    },
    {
      "text": "Which type of AML is known as Di Guglielmo disease?",
      "choices": [
        {
          "id": 1,
          "text": "Acute myeloid leukemia - M2"
        },
        {
          "id": 2,
          "text": "Acute myeloid leukemia - M5"
        },
        {
          "id": 3,
          "text": "Acute myeloid leukemia - M6"
        },
        {
          "id": 4,
          "text": "Acute myeloid leukemia  - M7"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Acute myeloid leukemia-M6 (AML-M6)</strong> or acute erythroid leukemia is known as <strong>Di Guglielmo disease</strong>.</p>\n<p>AML-M6<strong>&nbsp;</strong>accounts for&nbsp;1% of AML cases. It has two subtypes:</p>\n<ul>\n<li><strong>Erythroid/myeloid leukemia</strong> (M6a, more common) -&nbsp;Dyserythropoiesis is prominent</li>\n<li><strong>Pure erythroid leukemia</strong>/&nbsp;erythemic myelosis/&nbsp;<strong>Di Guglielmo disease</strong>&nbsp;(M6b, rare) -&nbsp;<strong>&nbsp;</strong>&gt;80% erythroid precursors. Clinical findings include anemia, thrombocytopenia, and variable neutropenia.</li>\n</ul>\n<p><strong>Positive stains </strong>for erythroid cells are glycophorin A, hemoglobin A, CD36, CD71, CD117, and PAS.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB3659",
      "difficulty": "medium"
    },
    {
      "text": "In patients with which of the following conditions, a dry tap may be seen on bone marrow aspiration?",
      "choices": [
        {
          "id": 1,
          "text": "Burkitt lymphoma"
        },
        {
          "id": 2,
          "text": "Acute myeloid leukemia - M6"
        },
        {
          "id": 3,
          "text": "Acute myeloid leukemia - M7"
        },
        {
          "id": 4,
          "text": "Undifferentiated leukemia"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Acute megakaryocytic leukemia (AML M7) </strong>may yield a <strong>dry tap</strong> on <strong>marrow aspiration.</strong></p>\n<p>It may be associated with <strong>extensive bone marrow fibrosis </strong>as a result of the stimulation of the normal fibroblasts by the local secretion of<strong> platelet-derived growth factor</strong>&nbsp;(PDGF) by the leukemic cells.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB3663",
      "difficulty": "medium"
    },
    {
      "text": "Bone marrow aspirate of a patient diagnosed with acute myeloid leukemia shows the presence of faggot cells. What is the most likely subtype of acute myeloid leukemia, the patient is suffering from?",
      "choices": [
        {
          "id": 1,
          "text": "Acute myeloid leukemia - M5"
        },
        {
          "id": 2,
          "text": "Acute myeloid leukemia - M4"
        },
        {
          "id": 3,
          "text": "Acute myeloid leukemia - M3"
        },
        {
          "id": 4,
          "text": "Acute myeloid leukemia - M2"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><span class=\"TextRun SCXW250557411\" lang=\"EN-GB\" xml:lang=\"EN-GB\"><span class=\"NormalTextRun SCXW250557411\">The presence of <strong>faggot cells</strong> is highly suggestive of acute myeloid leukemia - M3 <strong>(AML - M3) </strong>or <strong>acute promyelocytic leukemia</strong>.</span></span></p>\n<p><span class=\"TextRun SCXW250557411\" lang=\"EN-GB\" xml:lang=\"EN-GB\"><span class=\"NormalTextRun SCXW250557411\">A cluster of Auer rods is known as a f</span></span><span class=\"TextRun SCXW250557411\" lang=\"EN-GB\" xml:lang=\"EN-GB\"><span class=\"NormalTextRun SCXW250557411\">aggot cell. It is characteristic of acute myeloid leukemia (AML) M3.</span></span></p>\n<p><span class=\"TextRun SCXW250557411\" lang=\"EN-GB\" xml:lang=\"EN-GB\"><span class=\"NormalTextRun SCXW250557411\"><span class=\"TextRun SCXW208504445\" lang=\"EN-GB\" xml:lang=\"EN-GB\"><span class=\"NormalTextRun SCXW208504445\">The image given below shows </span></span><span class=\"TextRun SCXW208504445\" lang=\"EN-GB\" xml:lang=\"EN-GB\"><span class=\"NormalTextRun SCXW208504445\">AML M3 with a cluster&nbsp;of&nbsp;</span></span><span class=\"TextRun SCXW208504445\" lang=\"EN-GB\" xml:lang=\"EN-GB\"><span class=\"NormalTextRun SCXW208504445\">Auer rods (faggot cell).</span></span><span class=\"EOP SCXW208504445\" data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:259}\">&nbsp;</span></span></span></p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/992e91aad34548b2afb45308a673e17dx355x509.PNG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC0516",
      "difficulty": "easy"
    },
    {
      "text": "A patient diagnosed with acute myeloid leukemia presents with a one-day history of bleeding gums, subconjunctival bleed, and purpuric rash. Investigations done are given below. Which of the following genetic abnormalities is most likely to be detected?<div class='question-desc-html'><p>Hb: 6.4 gm/dL</p>\n<p>TLC: 26,500 cells/mm3</p>\n<p>Platelet: 35,000 mm3</p>\n<p>Prothrombin time: 20 sec with a control of 13 sec</p>\n<p>Partial thromboplastin time: 50 sec</p>\n<p>Fibrinogen: 10 mg/dL</p></div>",
      "choices": [
        {
          "id": 1,
          "text": "Inversion 16"
        },
        {
          "id": 2,
          "text": "t(8;21)"
        },
        {
          "id": 3,
          "text": "Inversion 3"
        },
        {
          "id": 4,
          "text": "t(15;17)"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The patient shows features of disseminated intravascular coagulation (DIC). It is most likely to be associated with acute myeloid leukemia - M3 or <strong>acute promyelocytic leukemia</strong>. The pathogenesis behind this is<strong>&nbsp;t(15,17)</strong> or&nbsp;<strong><em>PML-RARA</em> fusion gene</strong>.</p>\n<p>Option A: Inversion 16 is seen in acute myelomonocytic leukemia or AML - M4.&nbsp;</p>\n<p>Option B: t(8;21) is seen in AML with differentiation or AML - M2.</p>\n<p>Option C: Inversion 3 is seen in AML - M7 (megakaryoblastic) which shows normal or increased platelet count. It has a poor prognosis.</p>\n<p>&nbsp;</p><hr><h3>Related Pearl: Important Translocations in AML</h3><table>\n<tbody>\n<tr>\n<td>Translocation</td>\n<td>t(8,21)\n<p>(most common)&nbsp;</p>\n</td>\n<td>t(15,17)</td>\n<td>t(16,16) or inv(16)</td>\n</tr>\n<tr>\n<td>Fusion gene</td>\n<td>\n<p>RUNX1-RUNX1T1</p>\n</td>\n<td>PML-RAR&alpha;</td>\n<td>CBF-&beta; (Core binding factor)</td>\n</tr>\n<tr>\n<td>FAB classification</td>\n<td>\n<p>Blasts with maturation/M2</p>\n</td>\n<td>Acute promyelocytic leukemia/M3</td>\n<td>Myelomonocytic/M4</td>\n</tr>\n<tr>\n<td>Clinical association</td>\n<td>Myeloid sarcoma/ chloroma</td>\n<td>DIC</td>\n<td>Eosinophilia</td>\n</tr>\n<tr>\n<td>Prognosis</td>\n<td>Good</td>\n<td>Very good</td>\n<td>Good</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB3649",
      "difficulty": "medium"
    },
    {
      "text": "Which type of acute myeloid leukemia is myeloperoxidase negative?",
      "choices": [
        {
          "id": 1,
          "text": "Acute myeloid leukemia - M0"
        },
        {
          "id": 2,
          "text": "Acute myeloid leukemia - M1"
        },
        {
          "id": 3,
          "text": "Acute myeloid leukemia - M2"
        },
        {
          "id": 4,
          "text": "Acute myeloid leukemia - M4"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>AML M0</strong> is <strong>negative</strong> for myeloperoxidase (MPO).&nbsp;AML-M5 (monocytic), AML-M6 (erythroid), and AML-M7 (megakaryocytic)&nbsp;are also negative for MPO.&nbsp;</p>\n<p><strong>Myeloperoxidase</strong> (MPO) is located in the primary granules of<strong> neutrophils</strong> and their precursors, in <strong>eosinophil</strong> granules, and in the azurophilic granules of <strong>monocytes</strong>.&nbsp;</p>\n<p>The most primitive myeloblasts are negative, with granular positivity appearing progressively as they mature toward the promyelocyte stage. Promyelocytes and myelocytes are the most strongly staining cells in the granulocyte series. Monoblasts and monocytes may be negative or positive.</p>\n<p>AML-M4 shows both&nbsp;myelocytic&nbsp;and&nbsp;monocytic&nbsp;differentiation. Hence, it shows both MPO and non-specific esterase (marker for monocytes) positivity.&nbsp;</p><hr><h3>Related Pearl: FAB classification</h3><table>\n<tbody>\n<tr>\n<td><strong>FAB classification</strong></td>\n<td><strong>High-Yield points</strong></td>\n</tr>\n<tr>\n<td>M0-minimal differentiation</td>\n<td>-</td>\n</tr>\n<tr>\n<td>M1-without maturation</td>\n<td>-</td>\n</tr>\n<tr>\n<td>M2 - with maturation</td>\n<td>\n<ul>\n<li>Most common</li>\n<li>t(8,21)</li>\n<li>Chloromas</li>\n<li>Good prognosis</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>M3 - promyelocytic</td>\n<td>\n<ul>\n<li>Young-good prognosis</li>\n<li>t(15,17)-intermediate</li>\n<li>Auer rods</li>\n<li>DIC</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>M4 - myelomonocytic</td>\n<td>\n<ul>\n<li>inv 16</li>\n<li>t(16,16)</li>\n<li>Eosinophilia</li>\n<li>Gingival hyperplasia</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p>M5a - monoblastic</p>\n<p>M5b - monocytic</p>\n</td>\n<td>\n<ul>\n<li>Organ infiltration</li>\n<li>Gingival hyperplasia</li>\n<li>Increased WBC count, fever</li>\n<li>Sweet syndrome</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>M6 - erythroid</td>\n<td>\n<ul>\n<li>Therapy related</li>\n<li>Erythemic myelosis, Di&nbsp;Guglielmo disease</li>\n<li>Poor prognosis</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>M7 - megakaryocytic</td>\n<td>\n<ul>\n<li>CD 41/61</li>\n<li>Bad prognosis</li>\n<li>Down syndrome (good prognosis)</li>\n<li>Bone marrow fibrosis (increased PDGF)</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC0517",
      "difficulty": "medium"
    },
    {
      "text": "A patient with fatigue and recurrent infections undergoes bone marrow evaluation. It shows > 20% myeloblasts, which stain positive for CD61. What is the likely diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Acute promyelocytic leukemia"
        },
        {
          "id": 2,
          "text": "Acute megakaryocytic leukemia"
        },
        {
          "id": 3,
          "text": "Acute myelomonocytic leukemia"
        },
        {
          "id": 4,
          "text": "Acute monocytic leukemia"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The given clinical scenario with <strong>myeloblasts</strong> that stain positive for<strong> CD61</strong> is suggestive of<strong>&nbsp;acute megakaryocytic leukemia</strong> (AML-M7).</p>\n<p><strong>AML M7 </strong>is the<strong> l</strong><strong>east common type </strong>of <strong>AML.&nbsp;</strong>Blasts of megakaryocytic lineage predominate and are associated with <strong>marrow fibrosis.</strong> There is also frequent budding of cytoplasmic margins.<strong>&nbsp;</strong></p>\n<p>They are&nbsp;<strong>CD41+</strong>&nbsp;and&nbsp;<strong>CD61+</strong>.<strong>&nbsp;</strong>They stain negatively with Sudan black B (SBB) and myeloperoxidase (MPO). Blasts are reactive with <strong>PAS</strong>&nbsp;and&nbsp;<strong>acid phosphatase</strong>.</p>\n<p>The prognosis for this type of acute leukemia is poor.&nbsp;</p><hr><h3>Related Pearl: Panel of monoclonal antibodies for classification of leukemias</h3><table>\n<tbody>\n<tr>\n<td>\n<p>Haematopoetic</p>\n<p>precursors&nbsp;</p>\n</td>\n<td>CD34,Tdt, HLA-DR&nbsp;</td>\n</tr>\n<tr>\n<td>Myeloid&nbsp;</td>\n<td>CD13, CD33, CD15, MPO, CD117&nbsp;</td>\n</tr>\n<tr>\n<td>B cell&nbsp;</td>\n<td>CD19, CD20, CD22,&nbsp;CD79 a&nbsp;</td>\n</tr>\n<tr>\n<td>T cell&nbsp;</td>\n<td>CD2, CD3, CD5, CD7&nbsp;</td>\n</tr>\n<tr>\n<td>Monocytic&nbsp;</td>\n<td>CD11b, CD14&nbsp;</td>\n</tr>\n<tr>\n<td>Megakaryoblastic&nbsp;</td>\n<td>CD41, CD42, CD61&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: FAB classification</h3><table>\n<tbody>\n<tr>\n<td><strong>FAB classification</strong></td>\n<td><strong>High-Yield points</strong></td>\n</tr>\n<tr>\n<td>M0-minimal differentiation</td>\n<td>-</td>\n</tr>\n<tr>\n<td>M1-without maturation</td>\n<td>-</td>\n</tr>\n<tr>\n<td>M2 - with maturation</td>\n<td>\n<ul>\n<li>Most common</li>\n<li>t(8,21)</li>\n<li>Chloromas</li>\n<li>Good prognosis</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>M3 - promyelocytic</td>\n<td>\n<ul>\n<li>Young-good prognosis</li>\n<li>t(15,17)-intermediate</li>\n<li>Auer rods</li>\n<li>DIC</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>M4 - myelomonocytic</td>\n<td>\n<ul>\n<li>inv 16</li>\n<li>t(16,16)</li>\n<li>Eosinophilia</li>\n<li>Gingival hyperplasia</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p>M5a - monoblastic</p>\n<p>M5b - monocytic</p>\n</td>\n<td>\n<ul>\n<li>Organ infiltration</li>\n<li>Gingival hyperplasia</li>\n<li>Increased WBC count, fever</li>\n<li>Sweet syndrome</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>M6 - erythroid</td>\n<td>\n<ul>\n<li>Therapy related</li>\n<li>Erythemic myelosis, Di&nbsp;Guglielmo disease</li>\n<li>Poor prognosis</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>M7 - megakaryocytic</td>\n<td>\n<ul>\n<li>CD 41/61</li>\n<li>Bad prognosis</li>\n<li>Down syndrome (good prognosis)</li>\n<li>Bone marrow fibrosis (increased PDGF)</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB3647",
      "difficulty": "medium"
    },
    {
      "text": "A patient who developed the following lesions over the body was diagnosed with acute myeloid leukemia. Which subtype of AML does this patient most likely have?",
      "choices": [
        {
          "id": 1,
          "text": "Acute myeloid leukemia - M5"
        },
        {
          "id": 2,
          "text": "Acute myeloid leukemia - M3"
        },
        {
          "id": 3,
          "text": "Acute myeloid leukemia - M6"
        },
        {
          "id": 4,
          "text": "Acute myeloid leukemia - M2"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The given image shows<strong> leukemia cutis</strong>. It is seen in<strong> acute myeloid leukemia -&nbsp;M4 </strong>and <strong>acute myeloid leukemia -&nbsp;M5</strong>. It refers to leukemic cells infiltrating the skin.&nbsp;</p>\n<p>Signs and symptoms related to the&nbsp;involvement of tissues other than the marrow are usually less striking in AML than in acute&nbsp;lymphocytic&nbsp;leukemia (ALL). But tumors with<strong> monocytic differentiation</strong> (AML M4, M5) often<strong> infiltrate the skin</strong> (leukemia cutis) and the gingiva. This probably reflects the normal tendency of monocytes to extravasate into tissues.</p><hr><h3>Related Pearl: FAB classification</h3><table>\n<tbody>\n<tr>\n<td><strong>FAB classification</strong></td>\n<td><strong>High-Yield points</strong></td>\n</tr>\n<tr>\n<td>M0-minimal differentiation</td>\n<td>-</td>\n</tr>\n<tr>\n<td>M1-without maturation</td>\n<td>-</td>\n</tr>\n<tr>\n<td>M2 - with maturation</td>\n<td>\n<ul>\n<li>Most common</li>\n<li>t(8,21)</li>\n<li>Chloromas</li>\n<li>Good prognosis</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>M3 - promyelocytic</td>\n<td>\n<ul>\n<li>Young-good prognosis</li>\n<li>t(15,17)-intermediate</li>\n<li>Auer rods</li>\n<li>DIC</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>M4 - myelomonocytic</td>\n<td>\n<ul>\n<li>inv 16</li>\n<li>t(16,16)</li>\n<li>Eosinophilia</li>\n<li>Gingival hyperplasia</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p>M5a - monoblastic</p>\n<p>M5b - monocytic</p>\n</td>\n<td>\n<ul>\n<li>Organ infiltration</li>\n<li>Gingival hyperplasia</li>\n<li>Increased WBC count, fever</li>\n<li>Sweet syndrome</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>M6 - erythroid</td>\n<td>\n<ul>\n<li>Therapy related</li>\n<li>Erythemic myelosis, Di&nbsp;Guglielmo disease</li>\n<li>Poor prognosis</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>M7 - megakaryocytic</td>\n<td>\n<ul>\n<li>CD 41/61</li>\n<li>Bad prognosis</li>\n<li>Down syndrome (good prognosis)</li>\n<li>Bone marrow fibrosis (increased PDGF)</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/9d0a6b8939bc4dffaba3ee91d2e74a91.PNG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC0520",
      "difficulty": "medium"
    },
    {
      "text": "A 38-year-old man presents with bleeding gums for 20 days. He has gingival hyperplasia, hepatosplenomegaly, and lymphadenopathy. Investigations done are given below. Bone marrow biopsy shows 100% cellularity with many blasts cells that are peroxidase negative and non-specific esterase positive. What is the most likely diagnosis?<div class='question-desc-html'><p>Hb: 11 g/dL</p>\n<p>Platelet count: 95,000 platelets/mm3</p>\n<p>WBC count: 45000 cells/mm3.</p></div>",
      "choices": [
        {
          "id": 1,
          "text": "Acute myeloid leukemia - M2"
        },
        {
          "id": 2,
          "text": "Acute myeloid leukemia  - M0"
        },
        {
          "id": 3,
          "text": "Acute myeloid leukemia  - M5"
        },
        {
          "id": 4,
          "text": "Acute myeloid leukemia  - M7"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The given clinical scenario is suggestive of&nbsp;<strong>acute myeloid leukemia-M5</strong> (AML-M5)&nbsp;or acute monocytic leukemia.</p>\n<p>The patients with AML - M5 develop&nbsp;organomegaly, lymphadenopathy, gingival hyperplasia, CNS involvement, and other tissue infiltration. The bone marrow aspirate shows <strong>20% or more blasts</strong>.&nbsp;<strong>Monoblasts</strong> have folded or lobulated nuclei, <strong>lack Auer rods,</strong> and are nonspecific <strong>esterase positive</strong>.</p>\n<p><strong>Myeloperoxidase</strong> is present in the azurophilic granules of neutrophils and their precursors. It is positive in AML M1, M2, M3, M4 and negative in AML M0.&nbsp;Monoblasts and monocytes may be negative or positive. When positive, the granules are smaller than in neutrophils and diffusely scattered throughout the cytoplasm.</p>\n<p>The image given below shows bone marrow aspirate in AML - M5.</p><img src=\"https://cdn1.dailyrounds.org/uploads/092dd5c7a1ff4e75855bee3183248547x800x560.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: FAB classification</h3><table>\n<tbody>\n<tr>\n<td><strong>FAB classification</strong></td>\n<td><strong>High-Yield points</strong></td>\n</tr>\n<tr>\n<td>M0-minimal differentiation</td>\n<td>-</td>\n</tr>\n<tr>\n<td>M1-without maturation</td>\n<td>-</td>\n</tr>\n<tr>\n<td>M2 - with maturation</td>\n<td>\n<ul>\n<li>Most common</li>\n<li>t(8,21)</li>\n<li>Chloromas</li>\n<li>Good prognosis</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>M3 - promyelocytic</td>\n<td>\n<ul>\n<li>Young-good prognosis</li>\n<li>t(15,17)-intermediate</li>\n<li>Auer rods</li>\n<li>DIC</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>M4 - myelomonocytic</td>\n<td>\n<ul>\n<li>inv 16</li>\n<li>t(16,16)</li>\n<li>Eosinophilia</li>\n<li>Gingival hyperplasia</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p>M5a - monoblastic</p>\n<p>M5b - monocytic</p>\n</td>\n<td>\n<ul>\n<li>Organ infiltration</li>\n<li>Gingival hyperplasia</li>\n<li>Increased WBC count, fever</li>\n<li>Sweet syndrome</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>M6 - erythroid</td>\n<td>\n<ul>\n<li>Therapy related</li>\n<li>Erythemic myelosis, Di&nbsp;Guglielmo disease</li>\n<li>Poor prognosis</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>M7 - megakaryocytic</td>\n<td>\n<ul>\n<li>CD 41/61</li>\n<li>Bad prognosis</li>\n<li>Down syndrome (good prognosis)</li>\n<li>Bone marrow fibrosis (increased PDGF)</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB3651",
      "difficulty": "easy"
    },
    {
      "text": "A child presents with bilateral proptosis. After evaluation, he is diagnosed with chloroma. Which of the following is not a marker for this condition?",
      "choices": [
        {
          "id": 1,
          "text": "Lysozyme"
        },
        {
          "id": 2,
          "text": "CD43"
        },
        {
          "id": 3,
          "text": "CD45"
        },
        {
          "id": 4,
          "text": "CD61"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>CD61 is a marker of acute megakaryoblastic leukemia, not chloroma. <strong>Lysozyme</strong>, <strong>CD43</strong>, <strong>CD45</strong>, CD117, and MPO are positive markers of <strong>chloroma</strong>.</p>\n<p>Chloroma, also called <strong>myeloid sarcoma</strong>, granulocytic sarcoma, or myeloblastoma is an <strong>extramedullary tumor</strong> that occurs in 2% to 14% of patients with<strong> AML</strong>. Frequent sites of involvement are:</p>\n<ul>\n<li>Skin</li>\n<li>Lymph nodes</li>\n<li>Gastrointestinal tract</li>\n<li>Bone</li>\n<li>Soft tissue, testis</li>\n<li>Peritoneum</li>\n</ul>\n<p>Orbital involvement of myeloid sarcoma is rare without any evidence of systemic involvement. <strong>Proptosis</strong> is the most common presentation. Other symptoms include lacrimal swelling, conjunctival mass lesion, retinal hemorrhages, ptosis, dystopia. <sup id=\"cite_ref-21\" class=\"reference\"></sup><sup id=\"cite_ref-22\" class=\"reference\"></sup>Decreased visual acuity and ocular movement restriction have also been reported.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB3660",
      "difficulty": "easy"
    },
    {
      "text": "In which of the following conditions are Arbiskov cells seen?",
      "choices": [
        {
          "id": 1,
          "text": "Leukemia cutis"
        },
        {
          "id": 2,
          "text": "Myeloblastoma"
        },
        {
          "id": 3,
          "text": "Di Guglielmo disease"
        },
        {
          "id": 4,
          "text": "Richter's syndrome"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Arbiskov&nbsp;cells</strong> are <strong>monocytes&nbsp;</strong>seen in<strong> myeloblastoma </strong>or chloroma.</p>\n<p><strong>Chloroma</strong>, also known as <strong>granulocytic sarcoma,</strong> is a hematopoietic stem cell tumor, where&nbsp;myeloblasts&nbsp;are located at&nbsp;extramedullary&nbsp;sites. Orbit is one of the most common sites of occurrences in pediatric population. It is seen in<strong> AML - M2</strong> most commonly.&nbsp;Other conditions associated are myelodysplastic and myeloproliferative syndromes.&nbsp;</p>\n<p>The image given below shows Arbiskov&nbsp;cells in chloroma.</p><img src=\"https://cdn1.dailyrounds.org/uploads/3aff3411414f4f69b01c3cc7db1943c3x649x454.JPEG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC0521",
      "difficulty": "medium"
    },
    {
      "text": "All-trans retinoic acid is used in the treatment of tumor that is associated with which of the following genetic aberrations?",
      "choices": [
        {
          "id": 1,
          "text": "PML-RARA"
        },
        {
          "id": 2,
          "text": "BCR ABL"
        },
        {
          "id": 3,
          "text": "cMYC"
        },
        {
          "id": 4,
          "text": "RUNX1 ETO"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>All-trans retinoic acid (ATRA) is used in the treatment of <strong>acute promyelocytic leukemia (APML)</strong>, which is associated with <strong>PML-RARA fusion gene</strong>.</p>\n<p>Acute promyelocytic leukemia (APML) is associated with a reciprocal translocation between chromosomes 15 and 17 producing a PML-RARA fusion gene. This fusion gene encodes for a chimeric protein, which consists of a part of the PML protein and a part of the&nbsp;retinoic acid receptor-&alpha; (RAR&alpha;).</p>\n<p>The normal&nbsp;RAR&alpha; binds to the DNA and activates the transcription in the presence of retinoids. However, the chimeric protein produced by PML-RARA has reduced affinity for retinoids. This causes inhibition of transcription, thereby preventing gene expression for cellular differentiation. This leads to the accumulation of myeloid progenitor cells.</p>\n<p>The condition is treated with all-trans retinoic acid. It binds to the PML-RARA chimeric protein. This causes conformational change such that the protein regains its normal function and activates DNA transcription.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD0603",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following cytogenetic changes suggest a favorable prognosis in patients with acute myeloid leukemia?",
      "choices": [
        {
          "id": 1,
          "text": "t (11q23;v) with diverse MLL fusion genes"
        },
        {
          "id": 2,
          "text": "Normal karyotyping with mutated NPM"
        },
        {
          "id": 3,
          "text": "Activating mutations in FLT3"
        },
        {
          "id": 4,
          "text": "Inversion (3)"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Normal karyotyping with&nbsp;mutated NPM</strong> indicates a <strong>favorable prognosis</strong> in acute myeloid leukemia <strong>(AML).</strong></p><hr><h3>Related Pearl: Prognostic Factors in Acute Myeloid Leukemia (AML)</h3><table>\n<tbody>\n<tr>\n<td><strong>Good prognosis&nbsp;</strong></td>\n<td><strong>Poor prognosis&nbsp;&nbsp;</strong></td>\n</tr>\n<tr>\n<td>Age &lt;40 years&nbsp;</td>\n<td>Age &lt;2 years or &gt;55 years&nbsp;</td>\n</tr>\n<tr>\n<td>M2,M3,M4 forms of AML&nbsp;&nbsp;</td>\n<td>M0, M6, M7 forms of AML&nbsp;</td>\n</tr>\n<tr>\n<td>TLC &lt; 25 &times; 10<sup>9</sup>/L&nbsp;</td>\n<td>TLC &gt; 100 &times; 10<sup>9</sup>/L&nbsp;</td>\n</tr>\n<tr>\n<td>Blast cell with Auer rods&nbsp;</td>\n<td>Deletions 5q, 7q, 20q&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>t(8;21); RUNX1/ ETO fusion gene&nbsp;</p>\n<p>t(15;17); PML/ RARA fusion gene&nbsp;</p>\n<p>t(16;16) or&nbsp;inv&nbsp;16; CBF1/ MYH1 fusion gene&nbsp;</p>\n</td>\n<td>\n<p>t(11q23;v) with diverse MLL fusion genes&nbsp;</p>\n<p>t(6;9)</p>\n<p>Inversion 3</p>\n</td>\n</tr>\n<tr>\n<td>Rapid response to therapy&nbsp;</td>\n<td>Delayed response to therapy&nbsp;</td>\n</tr>\n<tr>\n<td>Leukemia&nbsp;without preceding MDS&nbsp;</td>\n<td>AML with preceding MDS or anticancer drug exposure&nbsp;</td>\n</tr>\n<tr>\n<td>Normal karyotyping with&nbsp;mutated NPM</td>\n<td>Complex karyotypes&nbsp;</td>\n</tr>\n<tr>\n<td>Biallelic&nbsp;mutation in CEBPA</td>\n<td>Activating mutation in FLT3</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>TLC: Total leukocyte count</p>\n<p>MDS: Myelodysplastic syndrome</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC0518",
      "difficulty": "medium"
    },
    {
      "text": "Which among the following patients with acute myeloid leukemia has a good prognosis?",
      "choices": [
        {
          "id": 1,
          "text": "A 56-year-old patient who developed post-chemotherapy AML"
        },
        {
          "id": 2,
          "text": "An infant with AML having complex karyotype"
        },
        {
          "id": 3,
          "text": "A 60-year-old patient diagnosed with AML-M0 type"
        },
        {
          "id": 4,
          "text": "A patient with AML having Inversion 16"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Inversion 16</strong> is associated with<strong>&nbsp;</strong>a<strong> good prognosis</strong> in&nbsp;acute myeloid leukemia (AML).</p><hr><h3>Related Pearl: Prognostic Factors in Acute Myeloid Leukemia (AML)</h3><table>\n<tbody>\n<tr>\n<td><strong>Good prognosis&nbsp;</strong></td>\n<td><strong>Poor prognosis&nbsp;&nbsp;</strong></td>\n</tr>\n<tr>\n<td>Age &lt;40 years&nbsp;</td>\n<td>Age &lt;2 years or &gt;55 years&nbsp;</td>\n</tr>\n<tr>\n<td>M2,M3,M4 forms of AML&nbsp;&nbsp;</td>\n<td>M0, M6, M7 forms of AML&nbsp;</td>\n</tr>\n<tr>\n<td>TLC &lt; 25 &times; 10<sup>9</sup>/L&nbsp;</td>\n<td>TLC &gt; 100 &times; 10<sup>9</sup>/L&nbsp;</td>\n</tr>\n<tr>\n<td>Blast cell with Auer rods&nbsp;</td>\n<td>Deletions 5q, 7q, 20q&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>t(8;21); RUNX1/ ETO fusion gene&nbsp;</p>\n<p>t(15;17); PML/ RARA fusion gene&nbsp;</p>\n<p>t(16;16) or&nbsp;inv&nbsp;16; CBF1/ MYH1 fusion gene&nbsp;</p>\n</td>\n<td>\n<p>t(11q23;v) with diverse MLL fusion genes&nbsp;</p>\n<p>t(6;9)</p>\n<p>Inversion 3</p>\n</td>\n</tr>\n<tr>\n<td>Rapid response to therapy&nbsp;</td>\n<td>Delayed response to therapy&nbsp;</td>\n</tr>\n<tr>\n<td>Leukemia&nbsp;without preceding MDS&nbsp;</td>\n<td>AML with preceding MDS or anticancer drug exposure&nbsp;</td>\n</tr>\n<tr>\n<td>Normal karyotyping with&nbsp;mutated NPM</td>\n<td>Complex karyotypes&nbsp;</td>\n</tr>\n<tr>\n<td>Biallelic&nbsp;mutation in CEBPA</td>\n<td>Activating mutation in FLT3</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>TLC: Total leukocyte count</p>\n<p>MDS: Myelodysplastic syndrome</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB3665",
      "difficulty": "medium"
    }
  ]
}